Mitesco Inc
OTC:MITI
Mitesco Inc
Operating Income
Mitesco Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mitesco Inc
OTC:MITI
|
Operating Income
-$9.6m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-79%
|
CAGR 10-Years
-15%
|
DaVita Inc
NYSE:DVA
|
Operating Income
$1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Income
$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
CVS Health Corp
NYSE:CVS
|
Operating Income
$15.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Operating Income
$9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Income
$1.1B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
2%
|
See Also
What is Mitesco Inc's Operating Income?
Operating Income
-9.6m
USD
Based on the financial report for Mar 31, 2023, Mitesco Inc's Operating Income amounts to -9.6m USD.
What is Mitesco Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-15%
Over the last year, the Operating Income growth was -13%. The average annual Operating Income growth rates for Mitesco Inc have been -78% over the past three years , -79% over the past five years , and -15% over the past ten years .